AstraZeneca PLC (AZN.L) 21-04-20
Will shares in AstraZeneca PLC (AZN.L) continue to rally, setting new recent highs?
- Now trading at 8115p (at time of writing), the share price performance has been very strong.
- Will it come to an end, or is this trend your friend?
- Could this be the ideal opportunity for momentum traders?
- Whilst momentum has been strong, traders should remember that past performance is not necessarily an indication of the future.
- Technical traders should be mindful of new events, which can influence price action. Check our website and news outlets for updates.
- Shares -0% from 12-month highs; +43% from 12 month lows.
Latest News
15 Apr: Mainfirst reiterates its buy rating on AstraZeneca (AZN) and increased the target price to 8800p (from 8100p).
15 Apr: Morgan Stanley reiterates its equal weight rating on AstraZeneca (AZN) and increased the target price to 8600p (from 8250p).
15 Apr: Jefferies International reiterates its hold rating on AstraZeneca (AZN) and increased the target price to 7575p (from 7475p).
14 Apr: Astrazeneca announced that a trial for its new drug used to treat lung cancer would be un-blinded ahead of schedule, recommended by an Independent Data Monitoring Committee.
Source: Bloomberg, Reuters, Alpha Terminal, FT, DJ Newswires